Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

DANIMER SCIENTIFIC, INC.

(DNMR)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

DANIMER SCIENTIFIC, INC. : Financial Statements and Exhibits (form 8-K)

10/27/2021 | 07:50am EST

Item 9.01 Financial Statements and Exhibits

(a) Financial Statements of Business Acquired.

(1)

The audited consolidated balance sheet of Novomer as of December 31, 2020, and the related consolidated statements of operations, changes in stockholders' equity, and cash flows for the fiscal year ended December 31, 2020, and the notes to the consolidated financial statements of Novomer, and the Report of Katz, Nannis & Solomon, P.C., Independent Auditors, dated June 25, 2021, included as Exhibit 99.1 to this Form 8-K and incorporated herein by reference. (2) The unaudited consolidated balance sheet of Novomer as of June 30, 2021, and the related unaudited consolidated statements of operations, changes in stockholders' equity, and cash flows as of June 30, 2021 and for the six-month periods ended June 30, 2021 and 2020, and the notes to the condensed consolidated financial statements of Novomer, which are attached to this Form 8-K as Exhibit 99.2 and incorporated herein by reference.

(b) Pro Forma Financial Information.

Attached to this Form 8-K as Exhibit 99.3 are the following pro forma financial statements of the Company, in each case giving effect to the Company's acquisition of Novomer, which are incorporated herein by reference:

(1)

Unaudited pro forma condensed combined balance sheet as of June 30, 2021, and
the notes thereto; and
(2)
Unaudited pro forma condensed combined statements of operations for the
six-months ended June 30, 2021 and the year ended December 31, 2020, and the
notes thereto.



(d) Exhibits


The following exhibits are hereby filed as part of this Form 8-K:




Number     Exhibit

23.1       Consent of Katz, Nannis & Solomon, P.C., Independent Auditors to
           Novomer.

99.1       Audited consolidated balance sheet of Novomer as of December 31,
           2020, and the related consolidated statements of operations, changes
           in stockholders' equity, and cash flows for the fiscal year ended
           December 31, 2020, and the notes to the consolidated financial
           statements of Novomer, and the Report of Katz, Nannis & Solomon,
           P.C., Independent Auditors, dated June 25, 2021.

99.2       Unaudited consolidated balance sheet of Novomer as of June 30, 2021,
           and the related unaudited consolidated statements of operations,
           changes in stockholders' equity, and cash flows as of June 30, 2021
           and for the six-month periods ended June 30, 2021 and 2020, and the
           notes to the condensed consolidated financial statements of Novomer.

99.3       Unaudited pro forma condensed combined balance sheet as of June 30,
           2021, and the notes thereto, and unaudited pro forma condensed
           combined statements of operations for the six-months ended June 30,
           2021 and the year ended December 31, 2020, and the notes thereto,
           giving effect to the Company's acquisition of Novomer.



--------------------------------------------------------------------------------

© Edgar Online, source Glimpses

All news about DANIMER SCIENTIFIC, INC.
01/26Danimer Scientific Enters PHA-Focused Deal With Hyundai Oilbank; Shares Rise Pre-Bell
MT
01/25Danimer Scientific and Hyundai Oilbank Collaborate on Driving Global Growth of PHA and ..
BU
01/21DANIMER SCIENTIFIC : Appoints Michael A. Hajost as Chief Financial Officer - Form 8-K
PU
01/21DANIMER SCIENTIFIC, INC. : Entry into a Material Definitive Agreement, Change in Directors..
AQ
01/20Danimer Scientific Names Michael Hajost CFO; Shares Rise Pre-Bell
MT
01/20Danimer Scientific Appoints Michael A. Hajost as Chief Financial Officer
BU
01/20Danimer Scientific Announces Executive Changes
CI
01/20Danimer Scientific Appoints Michael A. Hajost as Chief Financial Officer, Effective Mar..
CI
01/11SHAREHOLDER ALERT : Robbins LLP is Investigating Danimer Scientific, Inc. (DNMR, DNMRWS) o..
BU
01/11Danimer Scientific to Attend the CJS Securities 22nd Annual New Ideas for the New Year ..
BU
More news
Analyst Recommendations on DANIMER SCIENTIFIC, INC.
More recommendations